155 related articles for article (PubMed ID: 31403246)
41. Multipronged design of theranostic nanovehicles with endogenous and exogenous stimuli-responsiveness for precise cancer therapy.
Yang R; An J; Zhu H; Yan X; Gao H
J Mater Chem B; 2019 Feb; 7(7):1160-1166. PubMed ID: 32254784
[TBL] [Abstract][Full Text] [Related]
42. In vivo Near-infrared Fluorescence Tumor Imaging Using DiR-loaded Nanocarriers.
Liu H; Wu D
Curr Drug Deliv; 2016; 13(1):40-8. PubMed ID: 26138681
[TBL] [Abstract][Full Text] [Related]
43. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.
Cheng Z; Levi J; Xiong Z; Gheysens O; Keren S; Chen X; Gambhir SS
Bioconjug Chem; 2006; 17(3):662-9. PubMed ID: 16704203
[TBL] [Abstract][Full Text] [Related]
44. Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia Treatment.
Abdellatif AAH; Hennig R; Pollinger K; Tawfeek HM; Bouazzaoui A; Goepferich A
Pharm Res; 2020 Oct; 37(11):217. PubMed ID: 33037505
[TBL] [Abstract][Full Text] [Related]
45. Accessing Structurally Diverse Near-Infrared Cyanine Dyes for Folate Receptor-Targeted Cancer Cell Staining.
König SG; Krämer R
Chemistry; 2017 Jul; 23(39):9306-9312. PubMed ID: 28339120
[TBL] [Abstract][Full Text] [Related]
46. Monofunctional carbocyanine dyes for bio- and bioorthogonal conjugation.
Shao F; Weissleder R; Hilderbrand SA
Bioconjug Chem; 2008 Dec; 19(12):2487-91. PubMed ID: 19053316
[TBL] [Abstract][Full Text] [Related]
47. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.
Su Z; Shi Y; Xiao Y; Sun M; Ping Q; Zong L; Li S; Niu J; Huang A; You W; Chen Y; Chen X; Fei J; Tian J
Int J Pharm; 2013 Apr; 447(1-2):281-92. PubMed ID: 23396258
[TBL] [Abstract][Full Text] [Related]
48. Achieving traceless ablation of solid tumors without recurrence by mild photothermal-chemotherapy of triple stimuli-responsive polymer-drug conjugate nanoparticles.
Du C; Ding Y; Qian J; Zhang R; Dong CM
J Mater Chem B; 2019 Jan; 7(3):415-432. PubMed ID: 32254729
[TBL] [Abstract][Full Text] [Related]
49. A near-infrared xanthene-based fluorescent probe for selective detection of hydrazine and its application in living cells.
Guo SH; Leng TH; Wang K; Shen YJ; Wang CY
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Dec; 223():117344. PubMed ID: 31319274
[TBL] [Abstract][Full Text] [Related]
50. A two-photon responsive naphthyl tagged p-hydroxyphenacyl based drug delivery system: uncaging of anti-cancer drug in the phototherapeutic window with real-time monitoring.
Singh AK; Kundu M; Roy S; Roy B; Shah SS; Nair AV; Pal B; Mondal M; Singh NDP
Chem Commun (Camb); 2020 Sep; 56(69):9986-9989. PubMed ID: 32720950
[TBL] [Abstract][Full Text] [Related]
51. Cerenkov-Activated Sticky Tag for In Vivo Fluorescence Imaging.
Das S; Haedicke K; Grimm J
J Nucl Med; 2018 Jan; 59(1):58-65. PubMed ID: 28912146
[TBL] [Abstract][Full Text] [Related]
52. Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy.
Huang C; Hu X; Hou Z; Ji J; Li Z; Luan Y
J Colloid Interface Sci; 2019 Jun; 545():172-183. PubMed ID: 30878783
[TBL] [Abstract][Full Text] [Related]
53. Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo.
Han C; Li Y; Sun M; Liu C; Ma X; Yang X; Yuan Y; Pan W
Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):161-6. PubMed ID: 23731383
[TBL] [Abstract][Full Text] [Related]
54. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models.
Zhang J; Jin W; Wang X; Wang J; Zhang X; Zhang Q
Mol Pharm; 2010 Aug; 7(4):1159-68. PubMed ID: 20524673
[TBL] [Abstract][Full Text] [Related]
55. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
Hu Y; Zeng F
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
[TBL] [Abstract][Full Text] [Related]
56. Ultrasensitive near-infrared fluorescence-enhanced probe for in vivo nitroreductase imaging.
Li Y; Sun Y; Li J; Su Q; Yuan W; Dai Y; Han C; Wang Q; Feng W; Li F
J Am Chem Soc; 2015 May; 137(19):6407-16. PubMed ID: 25923361
[TBL] [Abstract][Full Text] [Related]
57. "Switch off/switch on" regulation of drug cytotoxicity by conjugation to a cell targeting peptide.
Gilad Y; Firer MA; Rozovsky A; Ragozin E; Redko B; Albeck A; Gellerman G
Eur J Med Chem; 2014 Oct; 85():139-46. PubMed ID: 25084142
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and evaluation of folate-based chlorambucil delivery systems for tumor-targeted chemotherapy.
Guaragna A; Chiaviello A; Paolella C; D'Alonzo D; Palumbo G; Palumbo G
Bioconjug Chem; 2012 Jan; 23(1):84-96. PubMed ID: 22121907
[TBL] [Abstract][Full Text] [Related]
59. Chlorambucil labelled with the phenosafranin scaffold as a new chemotherapeutic for imaging and cancer treatment.
Miksa B; Sierant M; Skorupska E; Michalski A; Kazmierski S; Steinke U; Rozanski A; Uznanski P
Colloids Surf B Biointerfaces; 2017 Nov; 159():820-828. PubMed ID: 28888199
[TBL] [Abstract][Full Text] [Related]
60. NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.
Redy-Keisar O; Ferber S; Satchi-Fainaro R; Shabat D
ChemMedChem; 2015 Jun; 10(6):999-1007. PubMed ID: 25847527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
